Hikal announces the successful development of Favipiravir Active Pharmaceutical ingredient (API) and its intermediates
INDIA, MAY 16, 2020 (GPN): Hikal Limited, a leading manufacturer and supplier of API’s and intermediates globally today announced the successful development of Favipiravir Active Pharmaceutical ingredient (API) and its intermediates. Favipiravir is a generic version…